Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Cancer Research|February 19, 2009
E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and manBostjan Humar, Vanessa Blair, Amanda Charlton, et al.
The New Zealand Medical Journal|July 21, 2017
Where to from here? Posthumous healthcare data, digital e(lectronic)-mortality and New Zealand's healthcare futureKatie Hoeksema, Richman Wee, Alastair Macdonald, et al.
The New Zealand Medical Journal|May 8, 2020
An estimate of limited duration cancer prevalence in New Zealand using 'big' dataNaomi Brewer, Andrea Teng, June Atkinson, et al.
The Journal of Pathology|March 19, 2009
Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasiaDonghui Zou, Han-Seung Yoon, David Perez, et al.
The Journal of Urology|July 24, 2007
P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancerMasaaki Ito, Hiroyuki Nishiyama, Hiroaki Kawanishi, et al.
Scientific Reports|November 20, 2025
A set cover algorithm identifies minimal circulating tumour DNA sequencing targets for colorectal cancer detectionKit Moloney-Geany, Michael A Black, Robert C Day, et al.
Breast Cancer Research : BCR|July 9, 2009
Increased levels of active c-Src distinguish invasive from in situ lobular lesionsDonghui Zou, Han-Seung Yoon, Ahmad Anjomshoaa, et al.
Cancers|January 11, 2022
Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle TraffickingTom Brew, Nicola Bougen-Zhukov, Wilson Mitchell, et al.
Molecular Cancer|August 3, 2018
E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancerJoana Figueiredo, Soraia Melo, Kimberley Gamet, et al.
Cancers|January 11, 2022
E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC InhibitorsLyvianne Decourtye-Espiard, Nicola Bougen-Zhukov, Tanis Godwin, et al.
Pageof 6